Indivior Pharmaceuticals, Inc. - INDV

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Sep 30, 2026 SCHEDULE 13G Millennium Management LLC 5.4% 6,343,651 View
Sep 30, 2026 SCHEDULE 13G Millennium Group Management LLC 5.4% 6,343,651 View
Sep 30, 2026 SCHEDULE 13G Israel A. Englander 5.4% 6,343,651 View
Aug 13, 2026 SCHEDULE 13D/A — 0.63% 1,790,787 View
May 15, 2026 SCHEDULE 13G/A Madison Avenue International LP 3.5% 4,315,162 View
May 15, 2026 SCHEDULE 13G/A Madison Avenue Partners, LP 3.5% 4,315,162 View
May 15, 2026 SCHEDULE 13G/A EMAI Management, LLC 3.5% 4,315,162 View
May 15, 2026 SCHEDULE 13G/A Madison Avenue GP, LLC 3.5% 4,315,162 View
May 15, 2026 SCHEDULE 13G/A Caraway Jackson Investments LLC 3.5% 4,315,162 View
May 15, 2026 SCHEDULE 13G/A Eli Samaha 3.5% 4,315,162 View
May 13, 2026 SCHEDULE 13G/A Fuller & Thaler Asset Management, Inc. 3.72% 4,529,583 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.